STAT+: Gilead to buy cancer biotech Tubulis for more than $3 billion
STAT [Unofficial]
April 7, 2026
Gilead is buying the German biotech Tubulis for more than $3 billion, a move that will expand its oncology pipeline.
Discussion in the ATmosphere